In REDEFINE 1, which enrolled 3,400 adults without diabetes but with at least one weight-related condition, CagriSema led to an average weight loss of 20.4% at Week 68 , compared to 14.9% with semaglutide, 11.5% with cagrilintide, and 3% with placebo
PMID 12049666
Research demonstrates that co-administration produces amplified GH pulses exceeding the sum of individual peptide effects, suggesting receptor-level synergism between GHRH and ghrelin pathway activation
Basat S, Sivritepe R, Ortaboz D, Sevimalk E, Kk EV, et al
[7] [8] Patients with uncontrolled or symptomatic arrhythmias, particularly atrial fibrillation with rapid ventricular response or ventricular arrhythmias, should have these conditions optimized before starting tirzepatide
We will see after the fourth shot Tirzepatide really works